MSFS
IBB icon

Main Street Financial Solutions’s iShares Biotechnology ETF IBB Stock Holding History

Main Street Financial Solutions’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95M Sell
10,264
-84
-0.8% -$14.4K 0.13% 151
2026
Q1 		$1.75M Sell
10,348
-2,584
-20% -$442K 0.13% 151
2025
Q4 		$2.18M Buy
12,932
+4,238
+49% +$688K 0.16% 127
2025
Q3 		$1.26M Sell
8,694
-205
-2% -$28K 0.08% 214
2025
Q2 		$1.13M Sell
8,899
-274
-3% -$33.6K 0.08% 208
2025
Q1 		$1.17M Buy
9,173
+1,131
+14% +$153K 0.1% 174
2024
Q4 		$1.06M Sell
8,042
-110
-1% -$15.5K 0.1% 156
2024
Q3 		$1.19M Buy
8,152
+150
+2% +$21.7K 0.11% 170
2024
Q2 		$1.1M Buy
8,002
+82
+1% +$10.9K 0.1% 187
2024
Q1 		$1.09M Buy
7,920
+19
+0.2% +$2.6K 0.12% 166
2023
Q4 		$1.07M Sell
7,901
-47
-0.6% -$5.73K 0.14% 142
2023
Q3 		$972K Buy
7,948
+65
+0.8% +$8.27K 0.14% 145
2023
Q2 		$1M Sell
7,883
-144
-2% -$18.7K 0.13% 151
2023
Q1 		$1.04M Sell
8,027
-295
-4% -$38.6K 0.15% 146
2022
Q4 		$1.09M Sell
8,322
-492
-6% -$63.6K 0.17% 125
2022
Q3 		$1.03M Sell
8,814
-61
-0.7% -$7.58K 0.17% 127
2022
Q2 		$1.04M Buy
8,875
+116
+1% +$13.8K 0.13% 142
2022
Q1 		$1.14M Buy
8,759
+97
+1% +$12.6K 0.17% 129
2021
Q4 		$1.32M Sell
8,662
-421
-5% -$65.2K 0.19% 121
2021
Q3 		$1.47M Buy
9,083
+514
+6% +$86.5K 0.23% 104
2021
Q2 		$1.4M Buy
8,569
+566
+7% +$87.2K 0.23% 106
2021
Q1 		$1.21M Buy
8,003
+788
+11% +$125K 0.21% 111
2020
Q4 		$1.09M Buy
+7,215
New +$1.03M 0.22% 107

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Main Street Financial Solutions's IBB Position: Q2 2026 in Review

Main Street Financial Solutions reduced its iShares Biotechnology ETF (IBB) stake by 0.81% in Q2 2026, selling an estimated $14.4K and leaving 10,264 shares worth $1.95M. The position accounts for 0.13% of the portfolio, ranked #151.

Main Street Financial Solutions first reported a position in IBB in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.18M in Q4 2025. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Main Street Financial Solutions held 10,264 shares of iShares Biotechnology ETF worth $1.95M as of Q2 2026.
  • Main Street Financial Solutions sold 84 iShares Biotechnology ETF shares in Q2 2026, an estimated $14.4K.
  • iShares Biotechnology ETF made up 0.13% of Main Street Financial Solutions's portfolio in Q2 2026, its #151 holding.
  • Main Street Financial Solutions first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 23 quarters since.
  • Main Street Financial Solutions's iShares Biotechnology ETF position peaked at $2.18M in Q4 2025.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Main Street Financial Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.